168 related articles for article (PubMed ID: 1666444)
1. One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.
Molin L; Ruhnek-Forsbeck M; Svennerholm B
Scand J Infect Dis Suppl; 1991; 80():33-9. PubMed ID: 1666444
[TBL] [Abstract][Full Text] [Related]
2. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
3. One-year suppression of frequent recurrences of genital herpes with oral acyclovir.
Baker DA; Blythe JG; Kaufman R; Hale R; Portnoy J
Obstet Gynecol; 1989 Jan; 73(1):84-7. PubMed ID: 2642329
[TBL] [Abstract][Full Text] [Related]
4. Effect of acyclovir and prednisolone on the serological response in herpes zoster.
Bates CJ; Kudesia G; McKendrick MW
J Med Virol; 1996 Nov; 50(3):244-8. PubMed ID: 8923289
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of HSV strains isolated before and after treatment with acyclovir.
Svennerholm B; Vahlne A; Löwhagen GB; Widell A; Lycke E
Scand J Infect Dis Suppl; 1985; 47():149-54. PubMed ID: 3006229
[TBL] [Abstract][Full Text] [Related]
6. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.
Straus SE; Takiff HE; Seidlin M; Bachrach S; Lininger L; DiGiovanna JJ; Western KA; Smith HA; Lehrman SN; Creagh-Kirk T
N Engl J Med; 1984 Jun; 310(24):1545-50. PubMed ID: 6328297
[TBL] [Abstract][Full Text] [Related]
7. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
8. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
Baker DA
J Int Med Res; 1994; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
[TBL] [Abstract][Full Text] [Related]
9. [Antiviral therapy adjustment in corneal recipients using antibody testing in the aqueous humor].
Robert PY; Liekfeld A; Ranger-Rogez S; Jaekel C; Pleyer U; Adenis JP; Hartmann C
J Fr Ophtalmol; 2003 Apr; 26(4):350-4. PubMed ID: 12843891
[TBL] [Abstract][Full Text] [Related]
10. Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group.
Goldberg LH; Kaufman R; Kurtz TO; Conant MA; Eron LJ; Batenhorst RL; Boone GS
Arch Dermatol; 1993 May; 129(5):582-7. PubMed ID: 8481018
[TBL] [Abstract][Full Text] [Related]
11. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
12. [A clinical study of genital herpes and the clinical efficacy of acyclovir tablets].
Kumamoto Y; Hirose T; Ikegaki S; Inoke T; Gouro T; Tabata S; Yoshio H; Sakaoka H
Hinyokika Kiyo; 1988 Feb; 34(2):383-93. PubMed ID: 3376833
[TBL] [Abstract][Full Text] [Related]
13. Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins.
Gold D; Ashley R; Solberg G; Abbo H; Corey L
J Infect Dis; 1988 Dec; 158(6):1227-34. PubMed ID: 2848900
[TBL] [Abstract][Full Text] [Related]
14. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
15. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
16. Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection.
Mertz GJ; Eron L; Kaufman R; Goldberg L; Raab B; Conant M; Mills J; Kurtz T; Davis LG
Am J Med; 1988 Aug; 85(2A):14-9. PubMed ID: 3044076
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir resistant genital herpes virus infection in a patient with AIDS.
Marrero M; Alvarez M; Millan JC; Mas Lago P; Soler M; Diaz M
Acta Virol; 1991 Jan; 35(1):86-9. PubMed ID: 1683121
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
[TBL] [Abstract][Full Text] [Related]
19. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
20. The role of oral acyclovir in the management of genital herpes simplex.
Sacks SL
CMAJ; 1987 Apr; 136(7):701-7. PubMed ID: 3548933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
